Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (31-40 of 182) with videos related to

Pageof 19
Sort By:
Journal of Cell Science|February 6, 2009
Control of mitochondrial apoptosis by the Bcl-2 familyJoslyn K Brunelle, Anthony Letai
The FEBS Journal|March 22, 2016
Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promiseKristopher A Sarosiek, Anthony Letai
Cell Stem Cell|March 12, 2013
BCL-2 inhibition: stemming the tide of myeloid malignanciesLeah J Hogdal, Anthony Letai
Trends in Cell Biology|May 10, 2016
BOK: Oddball of the BCL-2 FamilyElizabeth A Brem, Anthony Letai
Cold Spring Harbor Symposia on Quantitative Biology|November 5, 2016
To Prime, or Not to Prime: That Is the QuestionDanielle S Potter, Anthony Letai
Blood Cancer Discovery|February 8, 2024
The Siren Song of SynergyPatrick D Bhola, Anthony Letai
Cancer Letters|January 11, 2012
BH3 profiling--measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisionsVictoria Del Gaizo Moore, Anthony Letai
Nature Reviews. Molecular Cell Biology|January 19, 2019
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteinsRumani Singh, Anthony Letai, Kristopher Sarosiek
Advances in Experimental Medicine and Biology|April 29, 2008
Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?Victoria Del Gaizo Moore, Anthony Letai
Cancer Cell|December 24, 2021
Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinationsAnthony Letai, Patrick Bhola, Alana L Welm
Pageof 19

Showing results (31-40 of 182) with videos related to

Sort By:
Pageof 19
Journal of Cell Science|February 6, 2009
Control of mitochondrial apoptosis by the Bcl-2 familyJoslyn K Brunelle, Anthony Letai
The FEBS Journal|March 22, 2016
Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promiseKristopher A Sarosiek, Anthony Letai
Cell Stem Cell|March 12, 2013
BCL-2 inhibition: stemming the tide of myeloid malignanciesLeah J Hogdal, Anthony Letai
Trends in Cell Biology|May 10, 2016
BOK: Oddball of the BCL-2 FamilyElizabeth A Brem, Anthony Letai
Cold Spring Harbor Symposia on Quantitative Biology|November 5, 2016
To Prime, or Not to Prime: That Is the QuestionDanielle S Potter, Anthony Letai
Blood Cancer Discovery|February 8, 2024
The Siren Song of SynergyPatrick D Bhola, Anthony Letai
Cancer Letters|January 11, 2012
BH3 profiling--measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisionsVictoria Del Gaizo Moore, Anthony Letai
Nature Reviews. Molecular Cell Biology|January 19, 2019
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteinsRumani Singh, Anthony Letai, Kristopher Sarosiek
Advances in Experimental Medicine and Biology|April 29, 2008
Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?Victoria Del Gaizo Moore, Anthony Letai
Cancer Cell|December 24, 2021
Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinationsAnthony Letai, Patrick Bhola, Alana L Welm
Pageof 19